Our study demonstrated that the deletion of BMPR1A suppressed viability, migratory and invasive abilities, and EMT process of lung cancer cell lines, indicating the oncogenic activity of BMPR1A in bone metastasis. The gene discussed is BMPR1A; the disease is lung carcinoma.